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Abstract
Saturated fatty acids are known to activate macrophages and induce vascular inflammation. Although cytokines from
activated macrophage influence other vascular cells, the influence of saturated fatty acids on the paracrine effect of
macrophages is not fully understood yet. Here we examined the impact of palmitate on the effect of macrophages on vascular
smooth muscle cells (SMCs) and their mediators. SMCs proliferation increased significantly after treatment with conditioned
media from palmitate-stimulated RAW264.7 cells. SMC migration was found to be greater after treatment with palmitate-
conditioned media. SM a-actin and SM22a were decreased in SMCs treated with palmitate-conditioned media. When
stimulated with palmitate, RAW264.7 cells secreted more bone morphogenetic protein (BMP)2 and BMP4 into the cell culture
media. SMC proliferation, migration, and phenotypic changes were attenuated after treatment of neutralizing antibodies
against BMPs or knockdown of BMPs with siRNA. The influences of these proteins were further confirmed by direct treatment
of recombinant BMP2 and BMP4 on SMCs. Particularly, the effects of BMPs on SMC migration on phenotypic change were
obvious, whereas their effect on SMC proliferation seemed not significant or modest. In conclusion, palmitate promoted
macrophages’ paracrine effects on SMC proliferation, migration, and phenotypic change. The effect of stimulated
macrophages was mediated, at least in part, by BMP2 and BMP4. These results suggest a novel mechanism linking saturated
fatty acids and the progression of vascular diseases that is possibly mediated by BMPs from macrophages.
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Introduction
Free fatty acid levels are often elevated in obese individuals and
patients with metabolic syndrome or diabetes, and predicts
cardiovascular events [1]. Although the mechanisms by which
free fatty acids affect vascular diseases such as atherosclerosis are
not completely understood, a growing body of evidence suggests
that they are involved in the promotion of vascular inflammation.
In particular, saturated fatty acids have been reported to activate
monocytes/macrophages and induce the production of several
inflammatory mediators such as tumor necrosis factor- a (TNF- a),
interleukin-6 (IL-6), and interleukin-1b (IL-1b) [2–4].
The proliferation and phenotypic changes of vascular smooth
muscle cells (SMCs) from a quiescent and contractile to a synthetic
form are critical in atherosclerosis. SMCs interact with other
vascular cells including endothelial cells, monocytes, and macro-
phages and these interactions can influence SMC phenotypes.
Known factors involved in the modulation of SMC phenotypes
include growth factors such as platelet-derived growth factor
(PDGF), angiotensin II, interleukins, and mechanical stimulation
[5].
Bone morphogenetic proteins (BMPs) constitute a large group in
the transforming growth factor-b superfamily [6]. They are known
for their key roles in signaling during embryogenesis and
remodeling of bone and other tissues. BMP expression is
upregulated in human atherosclerotic lesions [7] and is involved
in vascular calcification and inflammation [8]. BMP4 is proin-
flammatory when expressed in endothelial cells [9]. Although the
effects of BMP2 and BMP4 on vascular SMCs have been
evaluated in a few studies of pulmonary vasculature, their
relationships with SMCs are not fully understood [10–12].
Here, we examined the impact of palmitate on the paracrine
effects of macrophages on vascular SMCs. We investigated the
effects of palmitate-stimulated macrophages on SMC proliferation,
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migration, and phenotypic change. We hypothesized that BMPs
could mediate macrophage-dependent SMC changes and dem-
onstrated the role of BMP2 and 4 in the interactions between these
two cell types.
Methods
Materials
Sodium salt of palmitate, bovine serum albumin (BSA; fatty
acid-free and low endotoxin), phorbol 12-myristate 13-acetate
(PMA), b-mercaptoethanol, mouse monoclonal antibodies against
smooth muscle a-actin (SM a-actin) and SM22a were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s modified
Eagle’s medum (DMEM), RPMI 1640 medium, gentamycin, fetal
bovine serum (FBS) and Dulbecco’ phosphate buffered saline
(PBS) with Ca2+ and Mg2+ were obtained from Gibco (Grand
Island, NY, USA). Neutralizing antibodies against BMP2 and
BMP4 were obtained from LSBio (Seattle, WA, USA) and Abcam
(Cambridge, MA, USA), respectively. Isotype-matched control
IgG and recombinant BMPs were purchased from R&D Systems
(Minneapolis, MN, USA).
Preparation of palmitate
Palmitate was dissolved in 0.1 M NaOH/70% ethanol at 70uC.
It was then complexed with 10% fatty acid-free low endotoxin
BSA at 55uC for 10 minutes. A stock solution of 50 mM palmitate
was prepared before the experiment. Palmitate was used at a
concentration of 250 mM and the solution was adjusted to a pH of
7.4. Palmitate preparation was assessed for lipopolysaccharide
contamination with Limulus Amebocyte Lysate Assay (Lonza,
Basel, Switzerland), and the endotoxin level was ,0.05 EU/mL
through all experiments. Control solution containing ethanol and
BSA was prepared similarly.
Cell culture
Rat aortic smooth muscle cells (SMCs) were obtained from
BioBud Inc. (Seoul, Korea) and grown in DMEM containing 10%
heat-inactivated FBS, 100 U/mL penicillin and 100 mg/mL
streptomycin. RAW264.7 cells and human monocyte leukemia
cell line THP-1 were purchased from the Korean Cell Line Bank
(Seoul, Korea). RAW264.7 cells were grown in DMEM with 10%
FBS. THP-1 cells were maintained in medium supplemented with
10% FBS and 0.2% b-mercaptoethanol.
Bromodeoxyuridine (BrdU) incorporation assay
SMC proliferation was examined using a BrdU cell proliferation
assay kit (Millipore Chemicon, Billerica, MA, USA) according to
the manufacturer’s protocol.RAW264.7 cells were stimulated with
BSA control or palmitate (250 mM)for 4 hours. Conditioned
media were collected 20 hours later. PDGF that is known to
induce SMC proliferation [13] and phenotypic modulation [14]
was used with IL-1b for a positive control group. SMCs plated in
96-well plates (3,000 cells/well) were serum-starved for 24 hours
and treated with each conditioned media or PDGF (25 ng/mL)/
IL-1b (10 ng/mL) for 24 to 72 hours. The cells labeled with BrdU
for 4 hours and then fixed with fixing solution. The plates were
washed for three times and stained with anti-BrdU antibody for
1 hour. After three washes, peroxidase-conjugated secondary
antibody was added to well plates for 30 minutes. The substrate
solution was added, followed by incubation for 30 minutes. A
blocking solution was then added, and the absorbance of the
samples was measured at 450 nm multi-well plate reader. The
relative proliferation rates were presented as the percentage of
control. BrdU assay to examine the effect of recombinant BMPs
was conducted with the same manner.
Wound healing assay and Boyden chamber assay
SMCs were gently scraped with pipette tips. They were then
serum-starved for 24 hours and treated with conditioned media
from macrophages that had been stimulated with BSA control,
palmitate (250 mM) or they were treated with PDGF (25 ng/mL)/
IL-1b (10 ng/mL). Twenty-four hours later, the wound sites along
the scratches were examined and photographed at 100-fold
magnification. Widths of wound gaps after 24 hours were
measured on the photographs for comparison. Boyden chamber
assay was conducted using 8.0-mm pore transwell inserts (Corning,
Corning, NY, USA). Briefly, serum-starved SMCs were seeded in
the upper chamber (250 mL, 16105 cells/well in a 24-well plate).
Cell migration was stimulated by 750 mL of conditioned media or
PDGF/IL-1b to the lower well of the Boyden chamber. After 4-
24 hours of incubation, the surface of the upper membrane was
swabbed with a cotton-tipped applicator to remove non-migrating
cells. Inserts were fixed in methanol for 30 minutes and stained
with 1% crystal violet for 2 hours. For quantitative analysis, the
surface of membrane was eluted by methnol and optical density
was measured using a microplate reader. Boyden chamber assay to
test the effect of recombinant BMPs was performed with the same
manner.
Immunoblotting to assess SMC phenotype and BMP
production
The effect of palmitate-stimulated macrophages on SMC
phenotype was assessed by immunoblotting. Total cell lysates
were collected from the cells. Cell extracts were subjected to 10%
SDS-PAGE and proteins were electrotransferred to a polyvinyli-
dene difluoride membrane for immunoblot analyses. The
membrane was blocked in phosphate-buffered saline containing
0.05% Tween 20 and 5% nonfat dry milk. Immunoblotting was
performed with anti-SM a-actin. The reactive bands were
visualized with Supersignal West Dura Extended Duration
Substrate (Thermo Scientific, Waltham, MA, USA). In the
experiments using conditioned media, RAW264.7 cells were
treated with BSA control or palmitate (250 mM) for 4 hours and
the conditioned media were collected 20 hours later. SMCs were
serum-starved for 24 hours and treated with the conditioned
media or PDGF (25 ng/mL)/IL-1b (10 ng/mL) for 24 hours.
Steps of immunoblotting thereafter were the same as described
above. Primary antibodies were: anti-b-actin, anti-SM a-actin,
and anti-SM22a. Immunoblotting to evaluate the effect of
recombinant BMPs on SMC phenotypic change was performed
with the same manner. BMP proteins were detected by
immunoblotting in conditioned media after pull-down using
heparin Sepharose beads.
Quantitative real-time PCR
Total RNA from cells was isolated using the RNA extraction
reagent Trizol (Invitrogen, Carlsbad, CA, USA). The cDNA was
synthesized using Superscript III reverse transcriptase (Invitrogen)
according to manufacturer’s protocol. Real-time PCR was
performed to determine the mRNA levels of BMP2 and BMP4
in cells using LightCycler FastStart DNA Master SYBR Green I
mix (Roche Applied Science, Indianapolis, IN, USA) with a
LightCycler 480 System (Roche Applied Science), in accordance
with the manufacturer’s instructions. The primers used were as
follows: BMP2, 59-GGTCACAGATAAGGCCATTGC-39 (sense)
and 59-GCTTCCGCTGTTTGTGTTTG-39 (antisense); BMP4,
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59-AGGAGGAGGAGGAAGAGCAG-39 (sense) and 59-GAG-
GAAACGAAAAGCAGAGC-39 (antisense). GAPDH gene was
used as an internal control using primers, 59-TGGCCAAGGT-
CATCCATGACAAC-39 (sense) and 59-TCCAGAGGGGC-
CATCCACAGTCTTCTG-39 (antisense). Relative quantification
of each gene was calculated with the LightCycler 480 SW software
(Roche Applied Science).
Anti-BMP antibody treatment
To neutralize the effects of BMPs, we used commercially
available antibodies against human BMP2 and BMP4. THP-1
cells were differentiated into macrophages using 100 nM PMA in
media with 10% FBS. Three days later, the cells were washed with
PBS and incubated for another 22 hours in the same medium but
without FBS. On the day of the experiment, the cells were
incubated for 4 hours with 250 mM palmitate or BSA control.
Conditioned media were collected 20 hours later. Conditioned
media were treated with 2 mg/mL of anti-BMP2, anti-BMP4
antibodies, or both for 1 hour. Antibody-treated conditioned
media were added to serum-starved SMC for 24 hours.
Transfection of siRNA
BMP2 siRNA, BMP4 siRNA and scrambled control siRNA were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
THP-1 cells differentiated with PMA were transfected with 10 nM
of siRNA using Lipofectamine RNAiMAX Reagent (Invitrogen)
according to the manufacturer’s protocol. After 24 hour of siRNA
transfection, we determined BMP2 and BMP4 levels in whole cell
lysates by immunoblot analysis to confirm the silencing of these
proteins. The cells transfected with BMP siRNA were also
incubated for 4 hours with 250 mM palmitate-BSA complex or
BSA control and conditioned media were collected 20 hours later.
Statistical analysis
All data are presented as the mean 6 standard error of the
mean (SE). Statistical analysis between two groups was conducted
using Student’s t-test. Differences were considered statistically
significant if the p value was ,0.05 (2-sided). All data were
analyzed using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Conditioned media from palmitate-stimulated
macrophages promote SMC proliferation
The effects of palmitate-stimulated macrophages on SMC
proliferation were evaluated by BrdU assay. Proliferation of SMCs
increased 48 hours after treatment with conditioned media from
RAW264.7 cells that had been stimulated with palmitate. This
effect was modest compared to that of PDGF/IL-1b. The mean
increase was 26–31% for palmitate and 94–132% for PDGF/IL-
1b at 48–72 hours (Fig. 1A). Our results suggest that palmitate-
stimulated macrophages are involved in SMC proliferation.
Figure 1. Conditioned media from palmitate-stimulated macrophages promote SMC proliferation and migration. A. To evaluate SMC
proliferation, RAW 264.7 cells were stimulated with BSA control, palmitate (250 mM) for 4 hours. Conditioned media were collected 20 hours later.
SMCs were serum-starved for 24 hours and treated with each conditioned media or PDGF (25 ng/mL)/IL-1b (10 ng/mL). BrdU incorporation assay
showed that palmitate-conditioned media modestly increased cell proliferation compared to the control. B. In the wound healing assay, SMCs were
gently scraped with a pipette tips. SMCs were serum-starved and treated with each conditioned media or PDGF/IL-1b as described in BrdU assay.
Wound sites along the scratches were examined and photographed at 100-fold maginification. C. The width of the wound gap was measured on the
photograph and expressed as % of control. The wound gaps were shorter in cells treated with palmitate-conditioned media or PDGF/IL-1b. D. In
Boyden chamber assay, SMCs were incubated with each conditioned media or PDGF/IL-1b in the chamber for 4-24 hours. After crystal violet staining,
migrated cells in the filters were observed under a microscope (Olympus, Tokyo, Japan). E. In addition, after crystal violet staining, the surface of
membrane was eluted by methanol and optical density was measured using a microplate reader. Treatment with palmitate-conditioned media or
PDGF/IL-1b induced significant SMC migration. Data are means 6 SE of three independent experiments. *p,0.05 compared to treatment with
conditioned media from BSA control.
doi:10.1371/journal.pone.0029100.g001
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Conditioned media from palmitate-stimulated
macrophages promote SMC migration
The effects of palmitate-stimulated macrophages on SMC
migration were assessed by a wound healing and Boyden chamber
assay. In the wound healing assay, the widths of wound gaps were
shorter in cells treated with palmitate-conditioned media or
PDGF/IL-1b (Fig. 1B and 1C). Boyden chamber assay demon-
strated that palmitate-conditioned media and PDGF/IL-1b
induced significant SMC migration compared to the control
(Fig. 1D and 1E). These results indicate that palmitate-stimulated
macrophages are involved in promoting SMC migration.
Conditioned media from palmitate-stimulated
macrophages affect SMC phenotypes
To examine the paracrine effects of palmitate-stimulated
macrophages on SMC phenotype, we determined the effects of
conditioned media from palmitate-stimulated macrophages on SMC
contractile markers. RAW264.7 cells were stimulated with BSA
control or palmitate. SMCs treated with the conditioned media from
palmitate-stimulated cells or PDGF/IL-1b showed a decrease in SM
a-actin and SM22a compared to those treated with the conditioned
media from BSA control-treated cells (Fig. 2A and 2B).
BMP production by palmitate-stimulated macrophages
and its role in SMC proliferation, migration, and
phenotypic change
We examined conditioned media from palmitate-stimulated
macrophages to evaluate the mechanism of the effects on SMC.
When stimulated with palmitate, RAW264.7 cells secreted BMP2
and BMP4 into cell culture media (Fig. 3A). In real-time PCR,
mean mRNA levels of BMP2 and 4 were 4.3 and 5.2 times higher
in cells treated with the palmitate-conditioned media (Fig. 3B).
When palmitate-conditioned media was treated with the combi-
nation of anti-BMP2 and anti-BMP4, promotion of SMC
proliferation by the media was abrogated. Anti-BMP2 or anti-
BMP4 alone did not show significant effect on cell proliferation
(Fig. 4A). Promotion of SMC migration by palmitate-conditioned
media was inhibited by addition of anti-BMP2 or anti-BMP4 or
the combination of them (Fig. 4B). To determine whether the
SMC phenotypic change was BMP-dependent, we treated
conditioned media from macrophages differentiated from THP-1
cells without or with addition of anti-BMP antibodies. Immuno-
blots showed that anti-BMP4 and anti-BMP2/anti-BMP4 anti-
bodies inhibited the decrease of SM a-actin and SM22a (Fig. 4C
and 4D). THP-1 cell-derived macrophages were transfected with
Figure 2. Conditioned media from palmitate-stimulated macro-
phages change SMC phenotype. A. RAW 264.7 cells were treated
with BSA control orpalmitate for 4 hours and conditioned media were
collected 20 hours later. SMCs were serum-starved for 24 hours and
treated with conditioned media or PDGF/IL-1b for 24 hours. Immuno-
blots showed decreased SM a-actin and SM22a in cells treated with
conditioned media from palmitate-stimulated macrophages. B. The band
intensities were determined by quantitative densitometry. Data are
illustrated in arbitrary integrator units relative to b-actin and represent
the mean6 SE from three independent experiments. *p,0.05 compared
to treatment with conditioned media from BSA control.
doi:10.1371/journal.pone.0029100.g002
Figure 3. BMP production by palmitate-stimulated macrophag-
es. A. RAW 264.7 cells were treated with BSA control or palmitate
(250 mM) for 4 hours and conditioned media were collected 20 hours
later. BMP 2 and 4 secreted in the media were pulled down on heparin-
Sepharose columns and detected by immunoblotting. B. RAW 264.7
cells were treated with BSA control or palmitate for 4 hours, and then
incubated with fresh media for 20 hours. BMP2 and BMP4 mRNA levels
were analyzed by real-time PCR. Data are illustrated in arbitrary unit
relative control and represent the means 6 SE from three independent
experiments. *p,0.05 compared to control.
doi:10.1371/journal.pone.0029100.g003
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BMP2 or BMP4 or both siRNA and demonstrated knockdown of
BMPs (Fig. 4E). SMCs were treated with palmitate-conditioned
media from macrophages without or with knockdown of BMPs.
Immunoblots showed that knockdown of BMP4 or both BMPs
abrogated phenotypic change of SMCs (Fig. 4F). Treatment of
SMCs with recombinant BMP2 and BMP4 resulted in no
apparent changes in cell proliferation (Fig. 5A). In Boyden
chamber assay, however, recombinant BMP2 and BMP4
significantly promoted SMC migration (Fig. 5B). When recombi-
nant BMP2 or BMP4 were treated to SMCs, both BMPs
decreased the expression of contractile markers in a dose-
dependent manner (Fig. 5C). Taken together, these results indicate
that the effects of palmitate-conditioned media on SMCs are, at
least in part, BMP2- and BMP4-dependent.
Discussion
This study demonstrated that palmitate influences the paracrine
effects of macrophages. Palmitate-stimulated macrophages pro-
moted SMC proliferation and migration. In addition, these
macrophages decreased the levels of SMC contractile markers,
indicating that SMCs were changed into more synthetic forms.
These effects of palmitate-stimulated macrophages required the
secretion of BMP2 and BMP4, as demonstrated by the attenuation
of SMC proliferation, migration, and phenotypic changes after
treatment with neutralizing antibodies against BMPs or knock-
down of BMPs with siRNA. The influences of these proteins were
further confirmed by direct treatment of recombinant BMP2 and
BMP4 on SMCs. The effect of BMP4 was more consistent
compared to that of BMP2. Particularly, the effects of BMPs on
SMC migration or phenotypic change were more obvious,
whereas their effect on SMC proliferation seemed not significant
or modest at maximum. Collectively, these findings suggest a new
mechanism linking elevated saturated fatty acids and the
progression of vascular diseases, possibly mediated by BMP2
and BMP4 originating from macrophages.
Prior studies have provided evidence for a proinflammatory
effect of saturated fatty acids, particularly palmitate. In mouse and
human cells, palmitate induces cyclooxygenase-2 [2], IL-6 [3,15],
TNF-a [4], IL-8 [4,15], and IL-1b [4]. Here, we focused on BMPs
and found that BMP2 and BMP4 were produced at higher levels
by palmitate-stimulated macrophages compared to control
macrophages. Our results are in agreement with those of a recent
study showing that the incubation of human endothelial cells with
Figure 4. The effect of neutralization or knocking-down of BMPs on SMC proliferation, migration, and phenotypic change. A. THP-1
cells differentiated with PMA were stimulated with BSA control or palmitate for 4 hours and conditioned media were collected 20 hours later.
Palmitate-conditioned media were treated without or with 2 mg/mL of anti-BMP2, anti-BMP4, or both for 1 hour. Each conditioned media was added
to serum starved SMCs for 72 hours. Cell proliferation was analyzed by BrdU incorporation assay. Promotion of SMC proliferation by palmitate-
conditioned media was abrogated by combined treatment of anti-BMP2/anti-BMP4. B. Each conditioned media described above was added to SMCs
for 24 hours. Cell migration assay was conducted using Boyden chamber assay. Promotion of SMC migration by palmitate-conditioned media was
inhibited by treatment of anti-BMP2 or anti-BMP4 or combination of both. C. Each conditioned media described above was added to SMCs for
24 hours. Immunoblots showed that anti-BMP4 or anti-BMP2/anti-BMP4 combination inhibited phenotypic change of SMCs. D. The band intensities
were determined by quantitative densitometry. E. THP-1 cell-derived macrophages were transfected with BMP2 or BMP4 or both siRNA for 24 hours.
Immunoblots demonstrated knockdown of BMP2 or BMP4 or both BMPs in the macrophages. F. SMCs were treated with palmitate-conditioned
media from macrophages without or with knockdown of BMPs for 24 hours. Equal amount of protein were separated by SDS-PAGE, and
immunoblots showed that knockdown of BMP4 or both BMPs abrogated phenotypic change of SMCs. Data are illustrated in arbitrary integrator unit
relative to b-actin and represent the means 6 SE from three independent experiments. *p,0.05 compared to control. **p,0.05 compared to
palmitate-conditioned media treatment.
doi:10.1371/journal.pone.0029100.g004
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palmitate increases BMP4 production, and that 6 weeks of a high
fat diet elevated mRNA levels of BMP4 in mouse thoracic aorta
[16]. Toll-like receptor 4 is known to link fatty acids and
inflammation [17] and toll-like receptor 42/2 mice fed a high fat
diet do not induce vascular BMP4 [16]. However, the mechanism
of BMP production by palmitate-stimulated macrophages is
unclear, and is beyond the scope of our current study. To our
knowledge, the present study is the first to show that palmitate-
stimulated macrophages produce BMPs possessing important
paracrine effects. Furthermore, we observed similar effects of
conditioned media from stimulated RAW264.7 cells and THP-1
cell-derived macrophages. Based on these findings, the effect of
palmitate might not be limited to cells from a single species.
We found that BMP4 played a role in changing SMC
phenotype to the synthetic form. Several groups of investigators
have documented the effect of BMP4 in vascular cells. Sorescu
et al. reported that BMP4 produced in endothelial cells stimulates
monocyte adhesion which is dependent on NFkB and intercel-
lular adhesion molecule 1 [9]. The effects of BMP4 on SMC have
been examined by previous studies, mainly in the pulmonary
vasculature, but these findings have been inconsistent and context
and/or site-dependent. In a study of neointimal hyperplasia,
endothelial BMP4 expression was upregulated after carotid
ligation in mice and activated BMP4 signaling resulted in
decreased SMC proliferation and migration [18]. BMP4
inhibited proliferation of SMCs isolated from proximal pulmo-
nary arteries, while it stimulated that of SMCs from peripheral
arteries [10]. In another study, pulmonary microvascular
endothelial cells secreted BMP4 in response to hypoxia and
promoted proliferation and migration of vascular SMCs [11]. In
addition, two recent studies reported that BMP2, 4, and 6 can
regulate vascular SMC phenotypic change through myocardin-
related transcription factors [19,20].
BMP2 expression was found to be upregulated in atheroscle-
rotic lesions [7]. Nakaoka et al. showed that overexpression of
BMP2 using adenovirus results in reduced neointimal prolifera-
tion in a rat carotid injury model [21]. However, Anderson et al.
found that BMP4-deficient mice have reduced vascular SMC
proliferation and vascular remodeling, while there is no change in
vascular SMCs or vessels in BMP2-deficient mice under hypoxic
conditions [12]. In our study, BMP2 production increased in
macrophages stimulated with palmitate. We found that BMP2
also had significant influence on the migration and phenotypic
change of SMCs, although the effect was less consistent than that
of BMP4.
We note that our study has some limitations. First, a variety of
inflammatory mediators including growth factors, interleukins,
and TNF-a are involved in SMC phenotypic change, growth,
and migration [5,22]. Therefore, we cannot rule out the
possibility that other cytokines released from palmitate-stimulated
macrophages could also have affected SMCs. However, because
we demonstrated the effect of BMPs using neutralizing antibody,
gene knockdown, and direct treatment of recombinant proteins, it
is clear that BMP2 and 4 play a significant role in SMCs. Second,
we evaluated the effects of conditioned media from palmitate-
stimulated RAW264.7 cells and THP-1 cell-derived macrophag-
es. SMC responses to stimulants can depend on cell types, origins
of cells, and culture conditions. In this regard, although we
evaluated the effect of conditioned media from two kinds of
macrophages, further studies are required to extend these data to
other biological settings and translate them to human vascular
pathophysiology.
In conclusion, palmitate-stimulated macrophages promoted
vascular SMC proliferation and migration, and changed SMCs
to a more synthetic form. The effects of these stimulated
macrophages on SMC migration and phenotypic change were
Figure 5. The effects of recombinant BMP2 and BMP4 on SMC proliferation, migration, and phenotypic change. A. Quiescent SMCs
were treated with various concentration of BMP2 or BMP4 for 24 hours. Cell proliferation was analyzed by BrdU incorporation assay. Recombinant
BMP2 and BMP4 did not have obvious effects on SMC proliferation. B. SMC migration assessment was conducted using Boyden chamber assay and
BMP2 and BMP4 significantly promoted SMC migration. C. SMCs were treated with various concentration of recombinant BMP2 or BMP4 for 24 hours.
Equal amount of protein was separated by SDS-PAGE and immunoblots showed both recombinant BMPs induced phenotypic change of SMCs with
lowering expression of SM a-actin and SM22a.
doi:10.1371/journal.pone.0029100.g005
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mediated, at least in part, by BMP2 and BMP4. Our results
suggest a novel mechanism linking elevated saturated fatty acid
levels and the progression of vascular diseases, possibly mediated
by BMPs produced by macrophages.
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